Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Structural biology

Bacteria’s protein machinery may offer antibiotic target

Bacteria use a molecular ruler to ensure their protective polysaccharides are the right length.

molecular ruler pic

Source: JH Naismith et al

The polysaccharide chain (yellow circles) grows from the protein WbdA (yellow doughnut), along the coiled-coil ruler (purple), until it reaches a WbdD capping protein that stops the polysaccharide’s growth — almost as though it were a pair of scissors snipping a piece of string to the desired length

Many bacteria wrap themselves in a sugar coating to ward off attacks from our immune systems. An international team of researchers has now unveiled a snapshot of the molecular machinery that builds these protective polysaccharide chains, giving the first clear view of a sweet spot that could be a target for new antibiotics.

It also proves that the proteins involved in creating the sugary shield rely on a molecular ruler to ensure that the polysaccharides are just the right length to offer a robust defence, according to the research published in Nature Structural and Molecular Biology[1] on 15 December 2014.

“Everybody knows that these rulers exist – there are lots of examples – but we’ve never seen one at a molecular level,” says James Naismith, of the University of St Andrews, Fife, who was part of the research team.

Bacteria anchor their finished polysaccharides to a lipid in their outer membrane, forming a barrier that is also a major cause of septic shock. There are more than 180 known forms of these polysaccharides, of various lengths, but each bacterium seems to make their own to a carefully regulated size. Naismith and his colleagues used X-ray and ultraviolet analysis techniques to paint a detailed picture of the polysaccharide production line in a strain of Escherichia coli.

The process starts with a protein called WbdA, which is stuck to the inside of the bacterial membrane and links together mannose molecules into a polysaccharide chain. WbdA is joined to three long, helical proteins that twist together into a rigid rope – known as a coiled coil – which acts as the molecular ruler. The coiled coil is capped at the other end by another protein, WbdD[2], which halts the growth process when the growing polysaccharide reaches the end of the ruler.

“This is significant,” says Peng George Wang of Georgia State University in Atlanta, Georgia, who studies polysaccharide biochemistry, and was not involved in this research. “It’s been one of the big mysteries in biology for many years.”

The polysaccharides constructed by this strain of bacteria usually contain 14 mannose units, and are roughly 21 nanometres long. The researchers found that the coiled-coil ruler was 20 nanometres – perfect for building chains with the right number of sugar molecules. They also produced mutated E. coli bacteria that had smaller or larger rulers, and found that the microbes made polysaccharides that were correspondingly shorter or longer.

This is one of three processes that various types of bacteria use to make polysaccharides, and the first to be described in such detail. However, many microbes probably use the same molecular ruler, so understanding the process could eventually deliver a new way to tackle bacterial infections, says Naismith. Disrupting the function of the WbdD cap on the ruler, for example, could cause the polysaccharide to grow unchecked, rendering the molecules useless in a protective shield. In the war on infection, “we need as many targets as possible”, he says.

Wang points out that one of the major pharmaceutical uses for polysaccharides is in vaccines. The pneumococcal polysaccharide vaccine, for example, protects against infections caused by the bacterium Streptococcus pneumonia, and its efficacy depends on the length of the polysaccharide chains. “It’s an ID card for that strain of bacteria,” explains Wang.

In principle, microbes could be genetically engineered to make the desired length of polysaccharides for different vaccines, simply by changing the length of the coiled-coil molecular ruler. “I’m sure it could have practical applications,” he says.  

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067465

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Molecular ruler

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.